allergy banner

Videos


Articles


Citations: 3335

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Citations: 2330

The global burden of asthma: executive summary of the GINA Dissemination Committee Report

Masoli, M., Fabian, D., Holt, S., Beasley, R. Allergy. 2004; 59: 469-478

Citations: 1328

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 1300

A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force

Johansson, S.G.O., Hourihane, J., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T. et al. Allergy. 2001; 56: 813-824

Citations: 885

Position Paper - Allergen Standardization and Skin-Tests

Dreborg, S. and Frew, A. Allergy. 1993; 48: 49-54

Citations: 794

Allergenic pollen and pollen allergy in Europe

D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi-Maesano, I., Behrendt, H. et al. Allergy. 2007; 62: 976-990

Citations: 760

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J. et al. Allergy. 2005; 60: 309-316

Citations: 757

The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., W., et al. Allergy. 2014; 69: 868– 887

Citations: 664

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, .S., Høst, A. et al. Allergy. 2007; 62: 943-948

Citations: 617

EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy

Muraro, A, Werfel, T, Hoffmann-Sommergruber, K, Roberts, G, Beyer, K, Bindslev-Jensen, C, et al. Allergy 2014; 69: 1008– 1025

Citations: 1590

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 350

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Citations: 179

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Citations: 167

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844

Citations: 164

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Citations: 77

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Citations: 56

Is BCG vaccination affecting the spread and severity of COVID-19?

Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827

Citations: 55

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444

Citations: 52

Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?

Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819

The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine

Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 24 October 2021

Transcriptome-based identification of novel endotypes in adult atopic dermatitis

Lefèvre-Utile, A., Saichi, M., Oláh, P., et al. Allergy. First published: 24 October 2021

The Benefit of Late Readings in Patch Testing Depends both on Allergen and Patient Characteristics

Forkel, S., Schubert, S., Dickel, H., et al. Allergy. First published: 23 October 2021

Increased circulating CRTH2+Tregs are associated with asthma control and exacerbation

Chantveerawong, T., Sangkangjanavanich, S., Chiewchalermsri, C., et al. Allergy. First published: 22 October 2021

Automated dander dispersal in a cat Naturalistic Exposure Chamber (NEC)

Haya, L., Mehri, R., Somers-Neal, S., et al. Allergy. First published: 17 October 2021

Comparison of epidemiologic surveillance and Google Trends data on asthma and allergic rhinitis in England

Sousa-Pinto, B., Antó, J.M., Sheikh, A., et al. Allergy. First published: 19 October 2021

CD103 integrin identifies a high IL-10-producing FoxP3+ regulatory T cell population suppressing allergic airway inflammation

Tagkareli, S., Salagianni, M., Galani, I.-E., et al. Allergy. First published: 17 October 2021

RBD-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 Outbreaks

Blain, H., Tuaillon, E., Gamon, L., et al. Allergy. First published: 15 October 2021

Profound differences in IgE and IgG recognition of micro-arrayed allergens in hyper IgE syndromes

Garib, V., Ben-Ali, M., Kundi, M., et al. Allergy. First published: 15 October 2021

A Systematic Review of Parent Report Measures Assessing the Psychosocial Impact of Food Allergy on Patients and Families

Proctor, K.B., Tison, K., Estrem, H., et al. Allergy. First published: 13 October 2021

Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19

Zahn, T., Mhedhbi, I., Hein, S., et al. Allergy. First published: 12 October 2021

Engineered IL-10: a matter of affinity

Fernandez-Santamaria, R. and Satitsuksanoa, P. Allergy. First published: 09 October 2021

Real-life observational cohort verifies high efficacy of dupilumab for Chronic Rhinosinusitis with Nasal Polyps

van der Lans, R.J.L., Fokkens, W.J., Adriaensen, G.F.J.P.M., et al. Allergy. First published: 09 October 2021

Nutrient supplementation for prevention of viral respiratory tract infections in healthy subjects: a systematic review and meta-analysis

Vlieg- Boerstra, B., de Jong, N., Meyer, R., et al. Allergy. First published: 09 October 2021

Enrichment of infant formula with long-chain polyunsaturated fatty acids and risk of infection and allergy in the nationwide ELFE birth cohort

Adjibade, M., Davisse-Paturet, C., Bernard, J.Y., et al. Allergy. First published: 09 October 2021

Advances and highlights in T and B cell responses to drug antigens

Fernandez-Santamaria, R., Ariza, A., Fernandez, T., Cespedes, J., Labella, M., Mayorga, C. and Torres, M. Allergy. First published: 07 October 2021

Virus-like particles displaying recombinant Der p 1 zymogen to optimize IgG blocking antibody response

Jitthamstaporn, S., Sander, A.F. and Jacquet, A. Allergy. First published: 07 October 2021

Tissue eosinophils express the IL-33 receptor ST2 and type 2 cytokines in patients with eosinophilic esophagitis

Uchida, A.M., Lenehan, P.J., Vimalathas, P., et al. Allergy. First published: 06 October 2021

Allergic eye disease: blocking LTB4/C5 in vivo suppressed disease and Th2 & Th9 cells

Eskandarpour, M., Zhang, X., Micera, A., et al. Allergy. First published: 06 October 2021

No apparent impact of incremental dosing on eliciting dose at double-blind, placebo-controlled peanut challenge

Álvarez García, O., Bartra, J., Ruiz-Garcia, M., et al. Allergy. First published: 06 October 2021

The ICQ Asthma Algorithm: Inhaled corticosteroid Containing resCUE (ICQ) treatment for present and future asthma management

Papi, A., Jesenak, M., Alfano, F., Peroni, D., Baraldi, F. and Diamant, Z. Allergy. First published: 06 October 2021

Legends of Allergy and Immunology: Giorgio Walter Canonica- physician, scientist and visionary leader

Heffler, E., Passalacqua, G. and Moretta, L. Allergy. First published: 05 October 2021

Identification of Chronic Urticaria Subtypes Using Machine Learning Algorithms

Türk, M., Ertaş, R., Zeydan, E., et al. Allergy. First published: 04 October 2021

Pros and cons: Should AIT be considered in all patients with allergic asthma?

Gerth van Wijk, R. and Dahl, R. Allergy. First published: 04 October 2021

Allergoid-mannan conjugates imprint tolerogenic features in human macrophages

Benito-Villalvilla, C., Pérez-Diego, M., Subiza, J.L. and Palomares, O. Allergy. First published: 03 October 2021

Glutamine deficiency shifts the asthmatic state toward neutrophilic airway inflammation

Kim, J.-M., Im, Y.N., Chung, Y.-J., et al. Allergy. First published: 03 October 2021

A three-stage design for allergen immunotherapy trials

Tang, X., Rabin, R.L. and Yan, L.K. Allergy. First published: 02 October 2021

Neuron-macrophage interaction in the healing process of the skin

Soler Palacios, B. and Gutierrez, A. Allergy. First published: 02 October 2021

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Unexplained recurrent fever: when is autoinflammation the explanation?

Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course

Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Asthma and COVID-19: Is asthma a risk factor for severe outcomes?

Johnston, S.,L. Allergy. 2020; 75: 1543-1545

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Is BCG vaccination affecting the spread and severity of COVID-19?

Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

Predictors of treatment response in chronic spontaneous urticaria

Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981

Interleukin-31: The “itchy” cytokine in inflammation and therapy

Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997

Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review

Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016

Eczema herpeticum in atopic dermatitis

Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027

Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study

Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052

Direct assessment of individual skin barrier components by electrical impedance spectroscopy

Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106

Prenatal paraben exposure and atopic dermatitis-related outcomes among children

Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132

Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154

Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy

Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202

Identification of Ulocladium chartarum as an important indoor allergen source

Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206

Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis

Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214

Legends of allergy and immunology: Sergio Bonini

Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229

Medical algorithm: Peri-operative management of mastocytosis patients

Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235

Junior Members Corner



Dear JMs,


The EAACI 2021 Annual Congress will be taking place on 10 - 12 July in a hybrid format, with both a physical part that will be held in Krakow both a digital part to allow anybody to attend safely. You are still on time to register by clicking here to have full live access to EAACI Hybrid Congress 2021 (3 days) and full access On Demand until December 31, 2021.

This is the main event of the Academy, and one of the biggest international dedicated to Allergy and Clinical Immunology. It gathers thousands of delegates from all around the world, and offers simultaneous sessions covering all aspects of our specialty.

Don't miss this opportunity and join us!

As every year the Junior Member Assembly (JMA) has organised some meetings to share knowledge and opportunity among JMs.
Here the Agenda with the highly suggested appointments:

- Monday, 28 June 2021, 15:00-16:00 CET: Open JM Business Meeting.

Invited guest Prof. Cezmi Akdis with the talk “Future direction of epithelial barrier research in the allergy and immunology field”. You can register by clicking here.


- Saturday, 10 July 2021, 14:00-15:30 CET: JMA Scientific Symposium.

Three excellent speeches on the theme "Approaching infants at high risk of allergic disease":
- Dr R. Jiménez-Saiz, “Understanding immunological mechanisms that confer a higher risk of allergy”;
- Dr M. M. Kelleher, “Infants at high risk of food allergy: nutritional and skin barrier repair interventions”;
- Dr I. Eguiluz-Gracia, “Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies”.

- Sunday, 11 July 2021, 14:00-15:30 CET: JMA Educational Session.

Composed of three very current speeches on "Lessons learned from COVID-19 pandemic":
- Dr A. DunnGalvin, “Mental health during the COVID-19 pandemic: how to cope with job stress and build resilience”;
- “Infodemic and the lesson of the COVID-19 pandemic: how to tackle health-related misinformation”;
- Dr B. Moya, “COVID-19 vaccination: Separating facts from fiction for your patients”.

Save the dates!

Looking forward to meeting you all at the 2021 EAACI Annual Hybrid Congress!

Best regards,
The Junior Member Assembly


Social Media